Gemfibrozil
Back to searchMolecule Structure
Scientific Name
Gemfibrozil
Description of the Drug
Gemfibrozil is a lipid regulator that is used in the reduction of serum triglyceride levels in high-risk patients with hyperlipidemia.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01241
http://www.drugbank.ca/drugs/DB01241
Brand Name(s)
Emfib, Gemfibrozil, Lopid
Company Owner(s)
Cadila Healthcare Ltd, Apotex Inc, Teva Pharmaceuticals Usa Inc, Impax Pharmaceuticals, Sun Pharmaceutical Industries Inc, Invagen Pharmaceuticals Inc, Watson Laboratories Inc, Northstar Healthcare Holdings Ltd, Ascent Pharmaceuticals Inc, Chartwell Rx Sciences Llc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Peroxisome proliferator-activated receptor alpha | SINGLE PROTEIN | AGONIST | CHEMBL239 |
Clinical Trial(s)
Unichem Links
Atlas | gemfibrozil | |
SureChEMBL | SCHEMBL4813 | |
PharmGKB | PA449750 | |
Human Metabolome Database | HMDB0015371 | |
DrugBank | DB01241 | |
PubChem: Thomson Pharma | 14798621 | |
PubChem | 3463 | |
Mcule | MCULE-4563546953 | |
LINCS | LSM-2227 | |
Nikkaji | J40.721F | |
PDBe | 4TX | |
BindingDB | 50110590 | |
EPA CompTox Dashboard | DTXSID0020652 | |
DrugCentral | 1285 | |
Brenda | 6087 | |
ChemicalBook | CB9154247 | |
Guide to Pharmacology | 3439 | |
rxnorm | LOPID | GEMFIBROZIL |
PubChem: Drugs of the Future | 12013353 | |
KEGG Ligand | C07020 | |
ChEBI | 5296 | |
ZINC | ZINC000001530641 |